ENSRNOG00000004828 (Acvr1c)

rattus norvegicus

activin A receptor type 1C

Filter your results

Rattus norvegicus
Organism part
Showing 12 experiments:
Created with Highcharts 6.2.0adrenal glandbraincalcaneal tendoncolonforepaw flexor tendongastrocnemiusheartkidneyliverlungpatellar tendonskeletal muscle tissuespleensupraspinatus tendontestisthymusuterus
T
11 Yu - male, juvenile
T
11 Yu - female, juvenile
T
11 Yu - female, adult
T
11 Yu - female, adolescent
T
11 Yu - male, elderly
T
11 Yu - male, adult
T
11 Yu - male, adolescent
T
11 Yu - female, elderly
T
9 Merkin - Sprague-Dawley
T
9 Merkin - F344/Cr1
T
Organism parts - tendons - Mendias et al
T
9 Merkin - BN/SsNHsd
P
Proteomics
T
Transcriptomics
High
Medium
Low
Below cutoff
No data available

Filter your results

Kingdom
Species
Experiment type
Experimental variables
Regulation
-1
-1.8
1
1.3
Display log2-fold change
Download results
Log2-fold changeSpeciesGene nameComparisonExperimental variablesExperiment name
Adjusted p-valueLog2-fold change
9.4174 × 10-4-1.8
ENSRNOG00000004828'17beta-estradiol; 10 microgram per kilogram per day; male' vs '17beta-estradiol; 0 microgram per kilogram per day; male'compound, sexTranscription profiling by array of rat male and female mammary glands following exposure to exogenous estradiol
Adjusted p-valueLog2-fold change
9.7658 × 10-5-1.7
ENSRNOG00000004828'puromycin aminonucleoside; 12 milligram per kilogram' vs 'none' in 'puromycin aminonucleoside; kidney' at '29 day'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from repeat dosing studies: compounds starting with P to R.
Adjusted p-valueLog2-fold change
1.4472 × 10-9-1.5
ENSRNOG00000004828'caffeine; 10 milligram per kilogram' vs 'none' in 'caffeine; liver' at '9 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with C.
Adjusted p-valueLog2-fold change
1.1728 × 10-2-1.5
ENSRNOG00000004828'allopurinol; 150 milligram per kilogram' vs 'none' in 'allopurinol; kidney' at '29 day'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from repeat dosing studies: compounds starting with A.
Adjusted p-valueLog2-fold change
8.35 × 10-81.3
ENSRNOG00000004828'acetazolamide; 60 milligram per kilogram' vs 'none' in 'acetazolamide; kidney' at '6 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with A.
Adjusted p-valueLog2-fold change
1.2234 × 10-6-1.3
ENSRNOG00000004828'cisplatin; 3 milligram per kilogram' vs 'none' in 'cisplatin; liver' at '3 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with C.
Adjusted p-valueLog2-fold change
1.2361 × 10-2-1.3
ENSRNOG00000004828'cisplatin; 3 milligram per kilogram' vs 'none' in 'cisplatin; liver' at '24 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with C.
Adjusted p-valueLog2-fold change
1.454 × 10-2-1.3
ENSRNOG00000004828'17beta-estradiol; 10 microgram per kilogram per day; female' vs '17beta-estradiol; 0 microgram per kilogram per day; female'compound, sexTranscription profiling by array of rat male and female mammary glands following exposure to exogenous estradiol
Adjusted p-valueLog2-fold change
1.6743 × 10-7-1.2
ENSRNOG00000004828'cyclosporine A; 300 milligram per kilogram' vs 'none' in 'cyclosporine A; liver' at '3 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with C.
Adjusted p-valueLog2-fold change
7.8184 × 10-7-1.2
ENSRNOG00000004828'omeprazole; 100 milligram per kilogram' vs 'none' in 'omeprazole; liver' at '6 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with N to O.
Adjusted p-valueLog2-fold change
2.4688 × 10-5-1.2
ENSRNOG00000004828'imipramine; 30 milligram per kilogram' vs 'none' in 'imipramine; liver' at '3 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with F to I.
Adjusted p-valueLog2-fold change
8.5645 × 10-5-1.2
ENSRNOG00000004828'methapyrilene; 100 milligram per kilogram' vs 'none' in 'methapyrilene; liver' at '29 day'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from repeat dosing studies: compounds starting with J to M.
Adjusted p-valueLog2-fold change
4.2834 × 10-4-1.2
ENSRNOG00000004828'caffeine; 100 milligram per kilogram' vs 'none' in 'caffeine; liver' at '24 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with C.
Adjusted p-valueLog2-fold change
1.1836 × 10-31.2
ENSRNOG00000004828'ethinylestradiol; 10 milligram per kilogram' vs 'none' in 'ethinylestradiol; kidney' at '15 day'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from repeat dosing studies: compounds starting with D to E.
Adjusted p-valueLog2-fold change
2.5606 × 10-31.2
ENSRNOG00000004828'acquired epilepsy (VX-765)' vs 'normal'compound, diseaseTranscriptional profiling of rats with acquired epilepsy treated with two antiinflammatory drugs, VX-765 or Anakinra to study the blockade of IL-1β-mediated signaling in status epilepticus
Adjusted p-valueLog2-fold change
4.2594 × 10-31.2
ENSRNOG00000004828'ethinylestradiol; 3 milligram per kilogram' vs 'none' in 'ethinylestradiol; kidney' at '15 day'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from repeat dosing studies: compounds starting with D to E.
Adjusted p-valueLog2-fold change
8.839 × 10-3-1.2
ENSRNOG00000004828'puromycin aminonucleoside; 12 milligram per kilogram' vs 'none' in 'puromycin aminonucleoside; kidney' at '15 day'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from repeat dosing studies: compounds starting with P to R.
Adjusted p-valueLog2-fold change
9.066 × 10-91.1
ENSRNOG00000004828'allopurinol; 15 milligram per kilogram' vs 'none' in 'allopurinol; liver' at '24 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with A.
Adjusted p-valueLog2-fold change
2.9851 × 10-7-1.1
ENSRNOG00000004828'acetazolamide; 60 milligram per kilogram' vs 'none' in 'acetazolamide; liver' at '24 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with A.
Adjusted p-valueLog2-fold change
4.5273 × 10-71.1
ENSRNOG00000004828'cyclophosphamide; 150 milligram per kilogram' vs 'none' in 'cyclophosphamide; liver' at '9 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with C.
Adjusted p-valueLog2-fold change
3.8945 × 10-6-1.1
ENSRNOG00000004828'caffeine; 10 milligram per kilogram' vs 'none' in 'caffeine; liver' at '24 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with C.
Adjusted p-valueLog2-fold change
1.9885 × 10-51.1
ENSRNOG00000004828'omeprazole; 100 milligram per kilogram' vs 'none' in 'omeprazole; kidney' at '9 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with N to O.
Adjusted p-valueLog2-fold change
8.5552 × 10-51.1
ENSRNOG00000004828'allopurinol; 50 milligram per kilogram' vs 'none' in 'allopurinol; liver' at '24 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with A.
Adjusted p-valueLog2-fold change
1.223 × 10-31.1
ENSRNOG00000004828'ethinylestradiol; 1 milligram per kilogram' vs 'none' in 'ethinylestradiol; kidney' at '15 day'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from repeat dosing studies: compounds starting with D to E.
Adjusted p-valueLog2-fold change
1.3755 × 10-21.1
ENSRNOG00000004828'ethinylestradiol; 10 milligram per kilogram' vs 'none' in 'ethinylestradiol; kidney' at '29 day'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from repeat dosing studies: compounds starting with D to E.
Adjusted p-valueLog2-fold change
4.8914 × 10-21.1
ENSRNOG00000004828'2 weeks after L5 spinal nerve ligation' vs 'control'growth condition, timeRNA-seq of rat dorsal root ganglia after ligation to investigate central nervous system transcriptomics in chronic pain using agnostic splice site discovery methods
Adjusted p-valueLog2-fold change
1.9846 × 10-81
ENSRNOG00000004828'imipramine; 100 milligram per kilogram' vs 'none' in 'imipramine; liver' at '6 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with F to I.
Adjusted p-valueLog2-fold change
1.7348 × 10-61
ENSRNOG00000004828'imipramine; 30 milligram per kilogram' vs 'none' in 'imipramine; liver' at '6 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with F to I.
Adjusted p-valueLog2-fold change
5.1617 × 10-41
ENSRNOG00000004828'allyl alcohol; 10 milligram per kilogram' vs 'none' in 'allyl alcohol; liver' at '9 hour'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from single dose studies: compounds starting with A.
Adjusted p-valueLog2-fold change
3.078 × 10-3-1
ENSRNOG00000004828'17beta-estradiol; 1 microgram per kilogram per day; male' vs '17beta-estradiol; 0 microgram per kilogram per day; male'compound, sexTranscription profiling by array of rat male and female mammary glands following exposure to exogenous estradiol
Adjusted p-valueLog2-fold change
4.3733 × 10-31
ENSRNOG00000004828'acquired epilepsy (anakinra and VX-765)' vs 'normal'compound, diseaseTranscriptional profiling of rats with acquired epilepsy treated with two antiinflammatory drugs, VX-765 or Anakinra to study the blockade of IL-1β-mediated signaling in status epilepticus
Adjusted p-valueLog2-fold change
1.6727 × 10-2-1
ENSRNOG00000004828'ethionine; 250 milligram per kilogram' vs 'none' in 'ethionine; kidney' at '29 day'cohort, compound, organism part, timeTranscription profiling by array of rat liver and kidney after exposure to approximately 130 chemicals collected from repeat dosing studies: compounds starting with D to E.